Nilay Çöplü

Nilay Çöplü

Auto-generated profile, based on publicly available information

Nilay Çöplü

Ankara Bilkent Şehir Hastanesi, Tıbbi Mikrobiyoloji Kliniği, Ankara

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2012
Verified
Journal Article
Closed access
EBEşe Aslan Başbulut
Eşe Aslan Başbulut
AGAyşegül Gözalan
Ayşegül Gözalan
CSCemile Sönmez
Cemile Sönmez
NCNilay Cöplü
Nilay Cöplü
BKBerrin Körhasan
Berrin Körhasan
MEMustafa Ertek
Mustafa Ertek

29 July 2016 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
CSCemile Sönmez
Cemile Sönmez
NÇNilay Çöplü
Nilay Çöplü
AGAyşegül GÖZALAN
Ayşegül GÖZALAN
ÜYÜlkü Yilmaz
Ülkü Yilmaz
SBSelen Bi̇lEkli̇
Selen Bi̇lEkli̇
LÇLütfi Çöplü
Lütfi Çöplü
Pertussis is a vaccine-preventable disease that is transmitted from infected to susceptible individuals by respiratory route. Bordetella pertussis infection may occur at any age as neither vaccine nor natural infection induced immunity lasts life-long. This study was planned to demonstrate the serological evidence of infection among adults, to raise awareness among clinicians and to provide data for the development of strategies to protect vulnerable infants. A total of 538 patients (345 female, 193 male) ages between 18-87 years who had a complain of prolonged cough for more than two weeks were included in the study. Anti-pertussis toxin (PT) IgG and anti-filamentous hemagglutinin (FH) IgG levels from single serum samples were measured by an in-house ELISA test which was standardized and shown to be efficient previously. Anti-PT IgG antibody levels of ≥ 100 EU/ml were considered as acute/recent infection with B.pertussis. In our study, 9.7% (52/538) of the patients had high levels of anti-PT IgG (≥ 100 EU/ml) and among those patients 43 (43/52; 82.7%) also had high (≥ 100 EU/ml) anti-FHA IgG levels. There were no statistically significant differences in terms of age, gender, education level, DPT (diphtheria-pertussis-tetanus) vaccination history, smoking history or average daily cigarette consumption (p> 0.05) between the cases with high antibody levels (n= 52). When the symptoms and the presence of cases with high antibody levels were evaluated, it was detected that no one parameter was significantly different from others, except that 24.1% of the cases with inspiratory whooping had high anti-PT levels. There was also no statistically significant difference between high anti-PT levels ≥ 100 EU/ml and the patients with risk factors [smoking (21/200; 10.5%), presence of disease that cause chronic cough and/or drug usage (19/171; %11.1), and whole factors which cause chronic cough (32/306; %10.5)] and without risk factors (p= 0.581; p= 0.357; p= 0.249, respectively). The distribution of anti-PT IgG geometric mean titer (GMT) according to the age groups, was as follows; 32.41 in 18-30 years; 36.28 in 31-50 years; 36.82 in 51-70 years and 31.15 in ≥ 71 years. Our results indicated that B.pertussis infections are also present among adult population with a frequency not to be underestimated (9.7%) and the results also emphasized that since typical whooping cough symptoms may not be seen in adults, pertussis infection should be considered as a differential diagnosis in adults with prolonged cough, even if there are some other underlying factors of cough. The data obtained from this study was also considered to be helpful in the development of adult vaccination policies for the protection of infants who have not completed the vaccination schedule yet.

24 November 2014 in Journal of Tropical Pediatrics
Verified
Journal Article
Open access
PDF file
ETEbru Türkoglu
Ebru Türkoglu
CSCemile Sönmez
Cemile Sönmez
ZKZafer Kurugöl
Zafer Kurugöl
NÇNilay Çöplü
Nilay Çöplü
GLG. Koturo Lu
G. Koturo Lu
Pertussis is a life-threatening, vaccine-preventable infection. Adults who can be asymptomatic may infect infants. The aim of this study is to determine the IgG antibody levels against pertussis toxin (PT) and filamentous hemagglutinin from 6 months to ≥60 years in Izmir, Turkey. A cluster sample design developed by Expanded Programme on Immunization of the World Health Organization was carried out for the selection of the study population, which consisted of 399 healthy subjects. In-house ELISA was studied in Turkish Public Health Institution. Antibody levels of <10 EU/ml, ≥10 EU/ml and ≥100 EU/ml were accepted as non-immune, immune and possible acute/recent infection, respectively. Anti-PT antibody levels were 8.5% <10 EU/ml, 68.2% 10–100 EU/ml and 23.3% ≥100 EU/ml; the latter was correlated with possible acute/recent infection. Results showed that pertussis is endemic, particularly among adolescents and adults, which is a threat for infants who have not completed their primary immunization.

1 January 2020 in Turkish Bulletin of Hygiene and Experimental Biology
Verified
Journal Article
Open access
AGAysegul Gozalan
Aysegul Gozalan
ÖÜÖzlem Ünaldı
Özlem Ünaldı
FKFisun Kıırca
Fisun Kıırca
NÇNilay Çöplü
Nilay Çöplü
TMTuba Muderris
Tuba Muderris
RDRiza Durmaz
Riza Durmaz

5 December 2022 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
BÇBüşra Çalışır
Büşra Çalışır
NÇNilay Çöplü
Nilay Çöplü
MDMelike Yaşar Duman
Melike Yaşar Duman
CKCetin Kilinc
Cetin Kilinc
RORidvan Ozbek
Ridvan Ozbek
ZEZafer Ergül
Zafer Ergül
OBJECTIVE: The aim of this study was to monitor the time-dependent change by evaluating the antibody levels at the 4th, 7th, 10th, 13th, and 16th weeks after the second dose of the CoronaVac vaccine.METHODS: The study group (n=65) were between 21 and 60 years old and received two doses of the CoronaVac vaccine. Blood samples were collected after 4th, 7th, 10th, 13th, and 16th weeks of the second dose of the vaccine administration. There was a coronavirus disease 2019 recovered group (n=29) who were SARS-CoV-2 real-time PCR test result positive before the vaccination period, and no coronavirus disease 2019 history group (n=36). Age, BMI, gender, smoking, comorbidity, coronavirus disease 2019 contact history, and working in the coronavirus disease 2019 service history of the individuals were recorded.RESULTS: No statistically significant difference was found in the descriptive findings of the individuals according to coronavirus disease 2019 recovered group and no coronavirus disease 2019 history group. It was observed that antibody levels in the coronavirus disease 2019 recovered group were found to be higher for each period of serum collection compared to the no coronavirus disease 2019 history group, which were statistically significant. The distribution curves of the antibody levels according to the timing of blood collection in coronavirus disease 2019 recovered group, no coronavirus disease 2019 history group, and total subjects were extrapolated, and it was observed that the estimated time for the antibodies to reach the threshold value of the test was 214, 145, and 166 days after vaccination.CONCLUSION: It is important to make booster doses, as the CoronaVac vaccine will lose its effect after the fifth month due to the decrease in Ab levels. In addition, since the antibody levels decrease later in those who have a history of coronavirus disease 2019 infection and are vaccinated, individuals who have no previous history of coronavirus disease 2019 should be given priority for vaccination.

18 June 2025 in Future Microbiology
Verified
Journal Article
Closed access
MGMerve Gürler
Merve Gürler
FKFüsun Kırca
Füsun Kırca
FTFigen Türen
Figen Türen
IKİrEm Tümkaya Kılınç
İrEm Tümkaya Kılınç
FAFerhat Gürkan Aslan
Ferhat Gürkan Aslan
BDBedia Dinç
Bedia Dinç
Central nervous system infections are a significant global health concern that results in morbidity and mortality. In case of these infections, empirical antibiotic treatment should be initiated according to the microbiological findings of the cerebrospinal fluid (CSF), and the treatment should be rearranged according to the antibiogram results.The study aimed to determine the distribution of meningitis agents and antimicrobial resistance patterns in our hospital. A total of 17,594 CSF culture samples collected from January 2020 to December 2024 were analyzed retrospectively. The study assessed demographic data, causative microorganisms, and antimicrobial resistance rates. Positive results were found in 7.3% of CSF culture samples, with 69.1% being gram-positive bacteria and 30.9% gram-negative bacteria. The highest positivity rate was detected in the palliative inpatient clinic (14.8%) despite most cultures being from the neonatal intensive care unit (23.5%). The most common microorganisms were coagulase-negative staphylococci(CoNS) (47.9%) and Klebsiella pneumoniae (K.pneumoniae) (9.1%). Methicillin resistance was present in 89.7% of CoNS, and the rate of extended-spectrum β-lactamase-producing strains in K.pneumoniae was 32.4%. Analysis of five-year data revealed the types of microorganisms and their antimicrobial resistance in positive CSF cultures. These findings will guide clinicians in promptly choosing the most effective empirical treatment.